Zobrazeno 1 - 10
of 526
pro vyhledávání: '"Ted, Feldman"'
Autor:
Matheus Simonato, Sreekanth Vemulapalli, Ori Ben-Yehuda, Changfu Wu, Larry Wood, Jeff Popma, Ted Feldman, Carole Krohn, Karen M. Hardy, Kimberly Guibone, Barbara Christensen, Maria C. Alu, Shmuel Chen, Vivian G. Ng, Katherine H. Chau, Bahira Shahim, Flavien Vincent, John MacMahon, Stefan James, Michael Mack, Martin B. Leon, Vinod H. Thourani, John Carroll, Mitchell Krucoff
Publikováno v:
The Annals of Thoracic Surgery. 113:1730-1742
Autor:
Michael J. Reardon, Ted Feldman, Joanna Van Houten, Shannon M. E. Murphy, Colin M. Barker, Matthew R. Reynolds, Sarah Mollenkopf
Publikováno v:
The American Journal of Cardiology. 147:94-100
There are limited data to support proposed increases to the minimum institutional mitral valve (MV) surgery volume required to begin a transcatheter mitral valve repair (TMVr) program. The current study examined the association between institutional
Autor:
Michael H. Salinger, Jorge Saucedo, Charanjit S. Rihal, Jeremy J. Thaden, Ron Waksman, Kenith Fang, William W. O'Neill, Hyde M. Russell, Akhil Narang, Saibal Kar, Lowell F. Satler, Igor F. Palacios, Mackram F. Eleid, Mayra Guerrero, Brad Lewis, Christopher Meduri, Marvin H. Eng, Ignacio Inglessis, Ted Feldman, Carl L. Tommaso, Paul J. Pearson, Tatiana Kaptzan, R Makkar, Philip Krause, Jae Oh, Dee Dee Wang, Vivek Rajagopal, Isaac George, Rebecca T. Hahn, Roberto M. Lang, Mark Reisman, Ashish Pershad, Martin B. Leon, Amit Pursnani, Ujala Bokhary, Susheel Kodali
Publikováno v:
JACC: Cardiovascular Interventions. 14:859-872
Objectives The aim of this study was to assess 1-year clinical outcomes among high-risk patients with failed surgical mitral bioprostheses who underwent transseptal mitral valve-in-valve (MViV) with the SAPIEN 3 aortic transcatheter heart valve (THV)
Autor:
Anastasia Jermihov, Hyde M. Russell, Tatiana Kaptzan, Gilbert H.L. Tang, Dee Dee Wang, William W. O'Neill, Igor F. Palacios, Michael H. Salinger, Jeremy J. Thaden, Amit Pursnani, Carl L. Tommaso, Ignacio Inglesis, Christopher Meduri, Vinayak Bapat, Charanjit S. Rihal, Mayra Guerrero, Ted Feldman, Brian Whisenant, Rebecca T. Hahn, Jae K. Oh, Mackram F. Eleid, Bradley R. Lewis, Pamela S. Douglas, G. Dangas, Susheel Kodali, Mark Reisman, Martin B. Leon, Philip Krause, Isaac George
Publikováno v:
JACC: Cardiovascular Interventions. 14:830-845
Objectives The aim of this study was to evaluate 1-year outcomes of valve–in–mitral annular calcification (ViMAC) in the MITRAL (Mitral Implantation of Transcatheter Valves) trial. Background The MITRAL trial is the first prospective study evalua
Autor:
Igor F. Palacios, Jae Oh, Brad Lewis, Rebecca T. Hahn, Saibal Kar, William W. O'Neill, Susheel Kodali, Richard W. Smalling, Christopher Meduri, Dee Dee Wang, Hyde M. Russell, Lowell F. Satler, Marvin H. Ng, Ted Feldman, Raj Makkar, Ashish Pershad, Amit Pursnani, Martin B. Leon, Pamela S. Douglas, Charanjit S. Rihal, Tarun Chakravarty, Tatiana Kaptzan, Mark Reisman, Mayra Guerrero, Jeremy J. Thaden, Mackram F. Eleid, RN Mary Gegenhuber, Carl L. Tommaso, Michael H. Salinger, Ron Waksman, Philip Krause
Publikováno v:
JACC: Cardiovascular Interventions. 14:846-858
Objectives The authors report 1-year outcomes of high-risk patients with failed surgical annuloplasty rings undergoing transseptal mitral valve–in–ring (MViR) with the SAPIEN 3 aortic transcatheter heart valve (THV). Background The MITRAL (Mitral
Autor:
William A. Gray, Sandra V. Abramson, Scott Lim, Dale Fowler, Robert L. Smith, Paul A. Grayburn, Susheel K. Kodali, Rebecca T. Hahn, Robert M. Kipperman, Konstantinos P. Koulogiannis, Mackram F. Eleid, Sorin V. Pislaru, Brian K. Whisenant, James M. McCabe, Jin Liu, Abdellaziz Dahou, Jyothy J. Puthumana, Charles J. Davidson, Ted Feldman, Suzanne Y. Gilmore, Ann Krzmarzick, Laura Gerik, Vanessa Wang, Annie Cao
Publikováno v:
JACC. Cardiovascular interventions. 15(19)
Tricuspid regurgitation (TR) is prevalent and undertreated, with mortality and morbidity increasing with TR severity. Given poor outcomes with medical therapy and high in-hospital mortality for isolated tricuspid valve surgery, emerging transcatheter
Autor:
Ted Feldman, Mackram F. Eleid, Dee Dee Wang, Mayra Guerrero, Charanjit S. Rihal, William W. O'Neill
Publikováno v:
Transcatheter Mitral Valve Therapies
Autor:
Ted Feldman
Publikováno v:
Transcatheter Mitral Valve Therapies. :125-137
Autor:
Michael Nabauer, Ralph Stephan von Bardeleben, Ted Feldman, Suzanne Y. Gilmore, Kai Friedrichs, Marcel Weber, Eustachio Agricola, Robert Schüler, Eric Brochet, Shekhar H Deo, Jörg Hausleiter, Rebecca T. Hahn, Felix Kreidel, Georg Nickenig, Stephan Baldus, Florian Deuschl, Francesco Maisano, J.-M. Juliard, Matteo Montorfano, Ulrich Schäfer, Efthymios Sotiriou, Azeem Latib, Hannes Alessandrini
Publikováno v:
EuroIntervention
AIMS: Tricuspid regurgitation (TR) is associated with high morbidity and mortality rates with limited treatment options. We report one- and two-year outcomes of the Cardioband tricuspid valve reconstruction system in the treatment of ≥moderate func
Autor:
Sorin V. Pislaru, Florian Deuschl, D. Scott Lim, Robert Kipperman, Paul A. Grayburn, Abdellaziz Dahou, Mark Reisman, Ted Feldman, Charles J. Davidson, Shekhar H Deo, Todd Zwink, Brian Whisenant, Robert L. Smith, Susheel Kodali, William A. Gray, Jyothy Puthumana, Cardioband Tr Efs Investigators, Konstantinos Koulogiannis, Dale Fowler, Mackram F. Eleid, Sandra Abramson, Rebecca T. Hahn, Prashanthi Vandrangi, Michael Minder
Publikováno v:
JACC: Cardiovascular Interventions. 14:41-50
Objectives The study reports for the first time the 30-day outcomes of the first U.S. study with the Cardioband tricuspid valve reconstruction system for the treatment of functional tricus...